跳至主要内容
临床试验/NCT01958216
NCT01958216Unknown不适用

In Vivo TICE (TransIntestinal Cholesterol Excretion) Measurement in Bile Duct Diverted Patients

Nantes University Hospital2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
5
试验地点
2
主要终点
Measuring trans-intestinal cholesterol excretion in vivo in bile diverted patients

研究概览

简要总结

So far, the liver has been the main target for cholesterol elimination. However, several recent studies performed in mice have described a new route of cholesterol excretion, the Trans-Intestinal Cholesterol Excretion or TICE. TICE allows direct elimination of plasma cholesterol in the feces directly via the intestine. Until now, only indirect evidence suggests that TICE is also active in humans, the goal of this proof of concept study is to provide the first proof of its existence in humans by using stable isotopes in patients with bile duct diversion.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • External bile duct diverted patients

排除标准

  • Inflammatory bowel disease
  • Renal or hepatocellular insufficiency
  • Primary intestinal tumor
  • Cholangitis or severe sepsis
  • Acute or chronic diarrhea

结局指标

主要结局

Measuring trans-intestinal cholesterol excretion in vivo in bile diverted patients

时间窗: Day 3

Measuring trans-intestinal cholesterol excretion in vivo in bile diverted patients

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验